Quarterly report pursuant to Section 13 or 15(d)

CONDENSED CONSOLIDATED STATEMENT OF CHANGES IN STOCKHOLDERS' EQUITY (DEFICIT) (Unaudited)

v3.21.2
CONDENSED CONSOLIDATED STATEMENT OF CHANGES IN STOCKHOLDERS' EQUITY (DEFICIT) (Unaudited) - USD ($)
$ in Thousands
Total
Cumulative Effect, Period of Adoption, Adjustment [Member]
Common Stock [Member]
Additional Paid-In Capital [Member]
Accumulated Other Comprehensive Loss [Member]
Accumulated Deficit [Member]
Accumulated Deficit [Member]
Cumulative Effect, Period of Adoption, Adjustment [Member]
Balance, beginning at Dec. 31, 2018 $ (21,708)   $ 37 $ 149,682 $ (69) $ (171,358)  
Balance, beginning (ASU 2016-02 [Member]) at Dec. 31, 2018   $ (29)         $ (29)
Balance, beginning (in shares) at Dec. 31, 2018     37,341,393        
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Beneficial conversion feature relating to convertible notes 3,374     3,374      
Exercise of warrants 5     5      
Exercise of warrants (in shares)     525        
Common stock issued for cash (net of issuance cost) 2,530   $ 1 2,529      
Common stock issued for cash (net of issuance cost) (in shares)     322,920        
Conversion of convertible note and promissory notes payable to common stock 329     329      
Conversion of convertible note and promissory notes payable to common stock (in shares)     85,411        
Share-based compensation 588     588      
Exercise of common stock options 1     1      
Exercise of common stock options (in shares)     175        
Foreign currency translation effect 7       7    
Net income (loss) (17,408)         (17,408)  
Balance, ending at Mar. 31, 2019 (32,311)   $ 38 156,508 (62) (188,795)  
Balance, ending (in shares) at Mar. 31, 2019     37,750,424        
Balance, beginning at Dec. 31, 2018 (21,708)   $ 37 149,682 (69) (171,358)  
Balance, beginning (ASU 2016-02 [Member]) at Dec. 31, 2018   (29)         (29)
Balance, beginning (in shares) at Dec. 31, 2018     37,341,393        
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Foreign currency translation effect 18            
Balance, ending at Sep. 30, 2019 (12,167)   $ 48 212,619 (51) (224,783)  
Balance, ending (in shares) at Sep. 30, 2019     47,671,446        
Balance, beginning at Dec. 31, 2018 (21,708)   $ 37 149,682 (69) (171,358)  
Balance, beginning (ASU 2016-02 [Member]) at Dec. 31, 2018   $ (29)         $ (29)
Balance, beginning (in shares) at Dec. 31, 2018     37,341,393        
Balance, ending at Dec. 31, 2019 (11,053)   $ 48 215,207 (79) (226,229)  
Balance, ending (in shares) at Dec. 31, 2019     48,471,446        
Balance, beginning at Mar. 31, 2019 (32,311)   $ 38 156,508 (62) (188,795)  
Balance, beginning (in shares) at Mar. 31, 2019     37,750,424        
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Beneficial conversion feature relating to convertible notes 5,390     5,390      
Exercise of warrants 181     181      
Exercise of warrants (in shares)     53,032        
Common stock issued for cash (net of issuance cost) 731     731      
Common stock issued for cash (net of issuance cost) (in shares)     76,755        
Share-based compensation 438     438      
Foreign currency translation effect 6       6    
Net income (loss) (17,596)         (17,596)  
Balance, ending at Jun. 30, 2019 (43,161)   $ 38 163,248 (56) (206,391)  
Balance, ending (in shares) at Jun. 30, 2019     37,880,211        
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Common stock issued for cash (net of issuance cost) 3,000   $ 1 2,999      
Common stock issued for cash (net of issuance cost) (in shares)     477,339        
Conversion of convertible note and promissory notes payable to common stock 35,459   $ 7 35,452      
Conversion of convertible note and promissory notes payable to common stock (in shares)     6,983,350        
Conversion note inducement 3,662     3,662      
Reclassification of warrant liability to permanent equity 6,336     6,336      
Exchange of common stock in connection with Merger (1,642)   $ 2 (1,644)      
Exchange of common stock in connection with Merger (in shares)     2,330,546        
Share-based compensation 129     129      
Fair value of replacement equity awards 2,437     2,437      
Foreign currency translation effect 5       5    
Net income (loss) (18,392)         (18,392)  
Balance, ending at Sep. 30, 2019 (12,167)   $ 48 212,619 (51) (224,783)  
Balance, ending (in shares) at Sep. 30, 2019     47,671,446        
Balance, beginning at Dec. 31, 2019 (11,053)   $ 48 215,207 (79) (226,229)  
Balance, beginning (in shares) at Dec. 31, 2019     48,471,446        
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Common stock issued for cash (net of issuance cost) 142   $ 1 141      
Common stock issued for cash (net of issuance cost) (in shares)     515,743        
Fair value of warrants including down-round protection adjustments 400     600   (200)  
Share-based compensation 209     209      
Foreign currency translation effect 61       61    
Net income (loss) 5,509         5,509  
Balance, ending at Mar. 31, 2020 (4,732)   $ 49 216,157 (18) (220,920)  
Balance, ending (in shares) at Mar. 31, 2020     48,987,189        
Balance, beginning at Dec. 31, 2019 (11,053)   $ 48 215,207 (79) (226,229)  
Balance, beginning (in shares) at Dec. 31, 2019     48,471,446        
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Foreign currency translation effect (7)            
Balance, ending at Sep. 30, 2020 (6,365)   $ 49 218,484 (86) (224,812)  
Balance, ending (in shares) at Sep. 30, 2020     48,987,189        
Balance, beginning at Mar. 31, 2020 (4,732)   $ 49 216,157 (18) (220,920)  
Balance, beginning (in shares) at Mar. 31, 2020     48,987,189        
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Share-based compensation 219     219      
Foreign currency translation effect (33)       (33)    
Net income (loss) (9,473)         (9,473)  
Balance, ending at Jun. 30, 2020 (14,019)   $ 49 216,376 (51) (230,393)  
Balance, ending (in shares) at Jun. 30, 2020     48,987,189        
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Fair value of warrants including down-round protection adjustments 1,983     1,987   (4)  
Share-based compensation 121     121      
Foreign currency translation effect (35)       (35)    
Net income (loss) 5,585         5,585  
Balance, ending at Sep. 30, 2020 $ (6,365)   $ 49 $ 218,484 $ (86) $ (224,812)  
Balance, ending (in shares) at Sep. 30, 2020     48,987,189